News | December 21, 2023
AGC invests US$ 348 million to expand its biopharmaceutical CDMO capability
Development services for gene and cell therapies is planned to begin first in 2025
Development services for gene and cell therapies is planned to begin first in 2025
Lokavant provides clinical trial intelligence
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes
The company now holds 56.61% of the total paid-up equity share capital of Sarvejana Healthcare
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Investment further strengthens Merck's "Big 3," the key drivers for increasing Group sales to approximately € 25 billion by 2025
A primary investment of Rs 194.4 crore has been made
Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities
Star Array's focus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology
Subscribe To Our Newsletter & Stay Updated
